Brief: Biocartis Enters Into Collaboration Agreement With Astrazeneca
22/01/2020 06:05
Jan 22 (Reuters) - Biocartis Group NV BCART.BR :
* REG-PRESS RELEASE BIOCARTIS GROUP: BIOCARTIS ENTERS INTO
MASTER
COLLABORATION AGREEMENT WITH ASTRAZENECA AND INITIATES EGFR
LIQUID BIOPSY STUDY
* BIOCARTIS GROUP NV - COLLABORATION AGREEMENT ENABLES
COLLABORATIVE DEVELOPMENT AND COMMERCIALIZATION OF IDYLLA BASED
MOLECULAR TESTS IN SUPPORT OF ASTRAZENECA'S PHARMACEUTICAL
PRODUCTS
Source text for Eikon: ID:nGNE1lPtdw
Further company coverage: BCART.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Biocartis NV
See all newsBrief: Biocartis Group NV Appoints Randy Polonsky As Chief Financial Officer
Brief: Biocartis Appoints New Chief Business Officer, VP Global Marketing
Brief: Biocartis And Merck To Collaborate
Brief: Biocartis's Secured Creditors Enforced Their Security Over Subsidiaries Shares
Brief: Biocartis Announces Expansion Of Its Collaboration With Apis Assay Technologies